Cleared Traditional

K192724 - Propeller Sensor for Symbicort

K192724 is an FDA 510(k) clearance for Propeller Sensor for Symbicort, manufactured by Reciprocal Labs Corporation. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 181-day FDA review.

K192724 · Reciprocal Labs Corporation · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2020
Decision
181d
Days
Class 2
Risk

K192724 is an FDA 510(k) clearance for the Propeller Sensor for Symbicort. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Reciprocal Labs Corporation (Madison, US). The FDA issued a Cleared decision on March 26, 2020 after a review of 181 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Reciprocal Labs Corporation devices

FDA 510(k) Submission Details - K192724

510(k) Number K192724 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 27, 2019
Decision Date March 26, 2020
Days to Decision 181 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
41d slower than avg
Panel avg: 140d · This submission: 181d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 190
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K192724.
Portable Mesh Nebulizer
K182906 · Feellife Health, Inc. · Sep 2020
AeroEclipse* ONE BAN
K200063 · Trudell Medical International · Jul 2020
GUS831 Compressor Nebulizer
K192633 · Globalcare Medical Technology Co., Ltd. · May 2020
Proneb Max
K191270 · Pari Respiratory Equipment, Inc. · Jan 2020
CapMedic
K183586 · Cognita Labs, LLC · Sep 2019
Hailie Sensor
K182638 · Adherium (Nz), Ltd. · Jun 2019